Trilema Salud

What Trilema Salud does

Trilema Salud is the health technology division of Spanish conglomerate Grupo Trilema, operating since 2014 under legal entity SOCIOEMPRENDE, S.L. from Valencia, Spain. The company builds and deploys MoviSalud, a cloud-based horizontal Personal Health Record (PHR) platform hosted on Amazon AWS in Ireland, featuring a distributed multi-layer architecture with mobile apps for iOS and Android, a professional web portal, bidirectional hospital information system integration, AEMPS medication database linkage, and Bluetooth connectivity to Google Fit, Apple Health, and direct device integrations with Werfen coagulometers and BÜHLMANN calprotectin tests. The platform includes a configurable library of 70+ self-control modules, a color-coded semaphore alert system, multi-level symptom decision trees, and integrated Moodle-based eLearning.

Trilema Salud generates revenue through a combination of subscription-based platform licensing to hospitals and pharmaceutical companies, project-based telemedicine implementations, custom software development and consulting, and health education services including in-house audiovisual content production through Trilema Digital. Its go-to-market is enterprise field sales targeting hospital pharmacy, cardiology, and oncology departments, with separate B2B partnerships with pharmaceutical laboratories for patient support programs. The company reports deployments across 50+ hospitals, 20+ pharmaceutical companies (including AMGEN, AstraZeneca, Bayer, Janssen, Novartis, Pfizer, Abbvie), and 4 Spanish scientific societies (SEOM, SEFH, SEC, SVR), with geographic presence in 11 Spanish autonomous communities and 4 international markets (Portugal, Poland, Belgium, Peru).

Notable sub-products include eOncoSalud (oncology pharmacy follow-up), CardioPlan (cardiac telerehabilitation), mHeart (transplant adherence, reporting 83% adherence conversion), ePrematur (neonatal follow-up), ControlaTAO (Sintrom anticoagulation), EntrenaEII (inflammatory bowel disease across 18 hospitals), and ONCOMMUN+ (European psycho-oncology platform). The company holds ENS and ISO/IEC 27001 certifications and operates with a lean team of 11 employees.

Name

Trilema Salud

Legal name

SOCIOEMPRENDE, S.L.

Website

https://trilemasalud.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Trilema Salud is the health technology division of Spanish conglomerate Grupo Trilema, operating the MoviSalud cloud platform for remote patient monitoring and chronic disease management across 50+ hospitals, 20+ pharmaceutical partners, and 5 countries, with 11 employees based in Valencia, Spain.

Ownership category

akta.pro rank

Product category

Digital Health Platform

NAICS

Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD), SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE), Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB)

Keywords

• Digital health platform
• Remote patient monitoring
• Telemedicine software
• Patient empowerment apps
• Health education eLearning

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Platform Licensing: Cloud-based MoviSalud platform deployed to hospitals, healthcare systems, and pharmaceutical companies for patient monitoring and self-care management.
2. Software Development and Consulting: Custom application development for health sector including analysis, design, programming, integration, implementation, and support services.
3. Health Education and eLearning: Patient education design, development of training products, eLearning platform hosting (Moodle), audiovisual content production, and professional training programs including FP Dual.
4. Telemedicine Project Implementation: End-to-end telemedicine project deployment including platform customization, clinical validation, and ongoing support for specific pathologies.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Trilema Salud develops and operates the MoviSalud cloud-based personal health record (PHR) platform, which enables remote patient monitoring, mobile health self-control, bidirectional messaging between patients and professionals, medication management (integrated with the AEMPS database), and wearable device connectivity for hospitals, healthcare systems, and pharmaceutical companies. Around the platform, the company provides consulting and custom software development for telemedicine projects and health education services (eLearning content, audiovisual production through Trilema Digital, and FP Dual vocational training).

Product overview

Trilema Salud operates a platform-plus-services model centered on the MoviSalud cloud healthcare platform. The core platform provides remote patient monitoring, mobile health self-control applications (PHR), bidirectional messaging, medication management, and professional web portals. Around this platform, Trilema delivers specialized vertical applications for specific therapeutic areas (cardiology, oncology, inflammatory bowel disease, transplant, neonatal, respiratory), health education services via Moodle eLearning, consulting and software development, and international projects. Products include eOncoSalud for oncology pharmacy, CardioPlan for cardiac rehabilitation, Fluye for childhood obesity prevention, NICEBEATS for heart failure education, ICOnnecta and ONCOMMUN+ for psycho-oncology support, EMMA Platform as an enterprise ecosystem, mHeart for transplant adherence, EntrenaEII for IBD, ControlaTAO for anticoagulation, and patient-facing apps like ActiveHIP+, ePrematur, and Ballesol cognitive programs. The company holds ENS and ISO 27001 certifications and operates across 15 regions/countries with presence in over 50 hospitals.

Differentiator

Problem solved

Functional benefit

Products and services

• MoviSalud Platform Cloud-based personal health record (PHR) platform enabling remote patient monitoring, mobile health self-control, bidirectional messaging between patients and professionals, medication management integrated with the AEMPS database, semaphore-based alerts, and wearable device connectivity. Delivered via web portal and iOS/Android apps to hospitals, healthcare systems, and pharmaceutical companies.
• Consulting and Software Development Services

Quantifiable outcome

• 83% of non-adherent heart transplant recipients became adherent at study end
• +2 more outcomes

Named customers18 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature8 records

Partnerships

26 partnerships are on record, tiered core and minor.

• AMGENcoreStrategic or Co-development PartnerStrategic collaboration since 2018 with AMGEN, a leading Spanish biotech company with ~80 clinical trials. Alliance focuses on care innovation and patient empowerment, adapting MoviSalud technology for therapeutic areas in Oncohematology, Cardiology, and Hospital Pharmacy. Joint development of EMMA platform integrating AMGEN's vertical applications.
• Abbvie (Abbott)coreStrategic or Co-development PartnerNational scope project for digestive services across 10 hospitals. Focus on patient management for inflammatory bowel diseases (Crohn's disease, ulcerative colitis). EntrenaEII project evolved with ISCIII support.
• Astellas PharmaminorStrategic or Co-development PartnerCollaboration with Hospital Sant Pau Cardiology Transplant Unit. Directed by pharmacy and cardiology for heart transplant patient management.
• AstraZenecacoreStrategic or Co-development PartnerWith cardiology departments of Fuenlabrada and Getafe hospitals. Patient management for heart failure and post-infarction rehabilitation phase.
• Bayer HispaniacoreStrategic or Co-development PartnerCollaboration with Spanish Society of Medical Oncology (SEOM): breast cancer patients nationwide multi-hospital project. With Pneumology Dept. of Hospital Clínic Barcelona: pulmonary hypertension patients. STIcare app for oncology patients treated with stivarga.
• Janssen CilagcoreStrategic or Co-development PartnerNational project for infectious diseases (HIV/HVC). Self-monitoring and follow-up of patients with AIDS and Hepatitis C.
• NovartiscoreStrategic or Co-development PartnerWith Hospital Vall d'Hebron Barcelona for pediatric asthma management. Won Hinnovar Award 2014. Lolo gamification character for child engagement.
• PfizercoreStrategic or Co-development PartnerWith Hospital La Fe pharmacy: clinical trial for batch control, expiration, and cold chain traceability for patients with biological therapies (rheumatoid arthritis). With Hospital La Paz hematology: prescription and dispensing management solution for hemophilia patients.
• Novo NordiskminorStrategic or Co-development PartnerWith Hospital La Fe pharmacy: pediatric patients with growth hormone deficiency. With Hospital Fuenlabrada endocrinology: diabetes mellitus type 2 follow-up.
• Biogen IdecminorStrategic or Co-development PartnerWith Hospital Virgen de las Nieves (Granada) pharmacy: multiple sclerosis patient management.
• Werfen Group (Izasa)coreTechnology or IntegrationDirect device integration with Werfen's coagulometer for Sintrom self-monitoring (ControlaTAO app). With Hospital Morales Meseguer for oral anticoagulation treatment management.
• Danone Spain / EcosistemacoreStrategic or Co-development PartnerWith Ecosistema (France) and 15 schools. Child education project for holistic health development in classrooms. Part of FLUYE project within 'Alimentando el Cambio' movement with Ashoka and Danone group.
• EIT HealthcoreStrategic or Co-development PartnerEuropean innovation program partner. Multiple projects: ACTIVEHIP+ (hip fracture rehabilitation), NICEBEATS (heart failure), ONCOMMUN (psycho-social oncology), EMMA Platform (healthcare integration). Cross-border initiatives in Spain, Portugal, Poland.
• Teva PharmaminorStrategic or Co-development PartnerWith Hospital Miguel Servet (Zaragoza) pharmacy: multiple sclerosis patient management and follow-up.
• UCB PharmaminorStrategic or Co-development PartnerWith Hospital Torrevieja neurology: pilot management of epilepsy patients.
• AllerganminorStrategic or Co-development PartnerWith private clinic network for dermatological treatments. Post-surgical monitoring design for botox patients.
• Bristol-Myers SquibbminorStrategic or Co-development PartnerOrencia product management. Platform design for rheumatoid arthritis patient management.
• CelgeneminorStrategic or Co-development PartnerHemato products management (Vidaza and Revlimid). Platform design for myelodysplastic syndrome (SDM) and multiple myeloma (MM) patient management.
• Nutricia Nestlé EspañaminorStrategic or Co-development PartnerWith Hospital Clínico Valencia pediatrics: pediatric obesity follow-up and control.
• OximesaminorStrategic or Co-development PartnerWith Hospital Marqués de Valdecilla pneumology: Self-Control Project telecontrol for COPD patients.
• Fundación AshokacoreStrategic or Co-development PartnerFLUYE project part of 'Alimentando el Cambio' movement, an initiative by Ashoka and Danone group to fight childhood obesity impacting 2+ million children.
• Instituto Pedro Nunes (Portugal)coreStrategic or Co-development PartnerCollaboration on 'Salud en Casa' COVID-19 home isolation project with Portuguese Ministry of Health. EIT Health partner for NICEBEATS, ONCOMMUN, and other European projects.
• GENUD University of ZaragozaminorStrategic or Co-development PartnerFLUYE project research lead for school-based health study.
• Vall d'Hebron Research Institute (VHIR)coreStrategic or Co-development PartnerePrematur project for premature neonatal follow-up after hospital discharge. Research initiative measuring health outcomes and cost efficiency.
• Nofer Institute of Occupational Medicine (Poland)minorStrategic or Co-development PartnerONCOMMUN project partner for psycho-social oncology across Spain, Portugal, and Poland.
• Amazon AWS (Ireland)coreTechnology or IntegrationCloud infrastructure provider hosting the MoviSalud platform on Amazon AWS servers located in Ireland.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Doximity: Doximity is a larger US telehealth and clinician platform that overlaps with Trilema's professional portal and telehealth messaging capabilities, though serving a much broader market.
• Health Catalyst: Health Catalyst is a broader healthcare data and analytics platform with chronic-care and population health modules serving US health systems. Comparable as a hospital-facing platform vendor with chronic-disease offerings, but at much larger scale.
• IQVIA (Patient Engagement / Digital Health): IQVIA offers enterprise patient engagement, real-world evidence, and clinical trial digital platforms serving pharma and providers globally. Overlaps with Trilema's pharma patient-support programs and clinical trial deployments.

Direct peers

• WellDoc: WellDoc develops digital therapeutics and chronic disease management software (e.g., diabetes, cardiovascular) with health system and pharma distribution. Comparable therapeutic-area coverage and SaaS delivery model.
• Voluntis: Voluntis develops digital therapeutics (DTx) and SaMD for chronic conditions including oncology and diabetes, partnering with pharma companies. Comparable to Trilema's condition-specific SaMD modules and pharma co-development model.
• Vivify Health: Vivify Health provides a remote patient monitoring platform with mobile apps, biometric device integration, and condition-specific care plans. Comparable to MoviSalud's device-integrated chronic-care model.
• Biofourmis: Biofourmis offers a cloud-based RPM and digital therapeutics platform with wearable integration, condition-specific modules, and pharma partnerships. Comparable to MoviSalud's RPM architecture and chronic-care DTx positioning.
• Medisafe: Medisafe provides a medication adherence and patient engagement platform with mobile apps, wearables integration, and pharma-sponsored patient support programs. Directly comparable to Trilema's mHeart, ControlaTAO, and adherence-tracking modules.
• Preventice Solutions (now Boston Scientific): Preventice provides connected cardiac monitoring and RPM with mobile apps and clinician portals. Comparable to Trilema's CardioPlan and mHeart cardiac telerehabilitation focus.

Regional players

• Savana: Savana is a Spanish clinical AI platform that processes EHR free-text for hospitals and research networks in Spain and Latin America. Comparable as a Spanish health-IT platform serving hospitals and pharma, though focused on NLP rather than patient engagement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/trilema_salud
• YouTubeyoutube.com/channel/UCk7tiqEhvlMIBFGf17gIExA
• LinkedInlinkedin.com/company/trilema-salud

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trilema Salud